Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

320
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
320
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

480
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
480
Clinical Trials01:16

Clinical Trials

10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

88
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
88
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

80
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
80

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduced conversion and readmission rates in robotic ileocecal resection for Crohn's disease: a propensity-matched analysis of the Hugo™ RAS system.

Surgical endoscopy·2026
Same author

Reliable classification of polyps based on artificial intelligence: a development and validation study.

EClinicalMedicine·2026
Same author

Age disparity in robotic colorectal surgery: overcoming surgeon hesitancy to improve elderly patient outcomes.

Journal of robotic surgery·2026
Same author

Applicability of mitotic figure counting by deep learning: a development and pan-cancer validation study.

FEBS open bio·2026
Same author

Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer.

Cancer discovery·2026
Same author

Surgical management of small bowel adenocarcinoma in Crohn disease: a multicenter retrospective analysis.

Inflammatory bowel diseases·2025

Related Experiment Video

Updated: Dec 18, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.0K

Compound optimal allocations for survival clinical trials.

Alessandro Baldi Antognini1, Marco Novelli1, Maroussa Zagoraiou1

  • 1Department of Statistical Sciences, University of Bologna, Bologna, Italy.

Biometrical Journal. Biometrische Zeitschrift
|June 16, 2020
PubMed
Summary

This study introduces a new method for optimal patient allocation in clinical trials with survival outcomes. It balances statistical inference and ethical considerations, ensuring more patients receive the best treatment without sacrificing study power.

Keywords:
censoringethicshypothesis testingoncological trialsresponse-adaptive randomization

More Related Videos

A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput
12:22

A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput

Published on: September 22, 2019

8.8K
Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

761

Related Experiment Videos

Last Updated: Dec 18, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.0K
A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput
12:22

A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput

Published on: September 22, 2019

8.8K
Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

761

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Survival Analysis

Background:

  • Comparative clinical trials with survival outcomes require careful patient allocation.
  • Balancing inferential demands (e.g., power, estimation efficiency) with ethical concerns (e.g., minimizing patient exposure to suboptimal treatments) is crucial.
  • Existing methods may not optimally address both aspects simultaneously.

Purpose of the Study:

  • To propose optimal patient allocation strategies for comparative clinical trials focusing on survival outcomes.
  • To develop a compound optimization strategy that subjectively weights the importance of statistical inference and ethical considerations.
  • To ensure that the proposed methods can be implemented using standard response-adaptive randomization procedures.

Main Methods:

  • A compound optimization strategy is employed, integrating inferential demands and ethical concerns.
  • Optimal targets are derived as continuous functions of treatment effects.
  • Conditions for approximating these targets with response-adaptive randomization are established, ensuring classical asymptotic inference.
  • Methodology is validated through theoretical analysis and simulation studies, assessing robustness to model misspecification.

Main Results:

  • The proposed strategy consistently allocates more patients to the superior treatment arm.
  • This allocation is achieved without compromising statistical inference, including estimation efficiency and statistical power.
  • The method demonstrates robustness to potential model misspecifications.
  • Simulations confirm the theoretical operating characteristics of the proposed allocation procedure.

Conclusions:

  • The developed methodology offers an improved approach to patient allocation in survival outcome clinical trials.
  • It effectively balances statistical rigor with ethical imperatives, prioritizing patient well-being.
  • The procedure is practical, adaptable to standard randomization techniques, and illustrated with real-world oncological trial examples.